TITLE

ANTI-INFLAMMATORY EFFECT OF N-ACETYLCYSTEINE (NAC) IN A MODEL OF COLITIS

AUTHOR(S)

Azooz, O.G.; De Silva, A.; Rampton, D.S.; Ballinger, A.B.

PUB. DATE

April 2003

SOURCE

Gut;Apr2003 Supplement 1, Vol. 52, pA61

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Introduction: Oxidative stress is a potential mechanism in the pathogenesis of inflammatory bowel disease (IBD) where reactive oxygen species (ROS) ore produced in excess by the intestinal mucosa. N-acetylcysteine (NAC) is a synthetic thiol compound which has antioxidant properties and suppresses production of NK-κB, and proinflammatory cytokines including TNF-α. Aims: The aim of this study was to assess the effect of NAC on the severity of colonic inflammation in a rat model of colitis. Methods: Colitis was induced in Wistar rats by intrarectal administration of 2,4,6 trinitrobenzenesulphonic acid (TNBS) and rats treated with i.p. NAC (50 or 200 mg/kg/day) or saline control (8/group). 16 healthy controls were treated with either NAC (50 mg/kg/day) or saline. Animals were sacrificed 5 days after induction of colitis. Severity of intestinal inflammation was assessed macroscopically, and by measurement of colonic tissue myeloperoxidase (MPO) and water content. ROS were measured by chemiluminescence (CLS). Results: TNBS induced distal colitis with ulceration, increased tissue MPO concentration and water content, and CLS (table). NAC reduced all these measures of intestinal inflammation except water content. There was no significant difference between 200 and 50 mg/kg of NAC. Conclusion: NAC has anti-inflammatory effects in the acute phase of TNBS-induced colitis. This treatment may be worth further assessment in the treatment of human IBD.

ACCESSION #

9747698

Tags: INFLAMMATORY bowel diseases;  INTESTINAL mucosa;  THIOLS

 

Related Articles

• Increased expression of tumor necrosis factor-a messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. Akazawa, Akiko; Sakaida, Isao; Higaki, Shingo; Kubo, Yoshitsugu; Uchida, Koichi; Okita, Kiwamu // Journal of Gastroenterology;2002, Vol. 37 Issue 5, p345 

  Background: Tumor necrosis factor-a (TNF-a), may be involved in the pathogenesis of inflammatory bowel diseases (IBDs). The aim of this study was to evaluate the effect of TNF-a on the inflammatory activity of IBD. Methods: TNF-a mRNA expression in intestinal mucosal biopsy specimens from IBD...

• Decreased Incorporation of 14C-Glucosamine Relative to 3H-N-Acetyl Glucosamine in the Intestinal Mucosa of Patients with Inflammatory Bowel Disease. Burton, A. F.; Anderson, F. H. // American Journal of Gastroenterology;Jan1983, Vol. 78 Issue 1, p19 

  The synthesis of glycoproteins was investigated in intestinal mucosa from patients with inflammatory bowel disease (IBD) and from those with various other conditions. The incorporation into acid-insoluble macromolecules of the amino sugar glucosamine, the first and committed metabolite in the...

• Immune-non Immune Networks in Intestinal Inflammation. Hausmann, Martin; Rogler, Gerhard // Current Drug Targets;May2008, Vol. 9 Issue 5, p388 

  The intestinal mucosa forms a primary barrier providing both barrier function and immediate effective recognition of bacterial products invading the mucosa. This is of great importance for the prevention of permanent and chronic inflammation as a reaction to the commensal intestinal flora and...

• Recent Understanding of Leukocytapheresis (LCAP) for the Treatment of Inflammatory Bowel Disease. Mitsuyama, Keiichi; Yamasaki, Hiroshi; Kuwaki, Kotaro; Takedatsu, Hidetoshi; Sata, Michio // Current Pharmaceutical Design;6/21/2009, Vol. 15 Issue 18, p2110 

  Inflammatory bowel disease (IBD) is frequently associated with the infiltration of a large number of leukocytes into the bowel mucosa. Therefore, the removal of circulating leukocytes may be an attractive approach for the treatment of IBD. Leukocytapheresis with Cellsorba, a column of...

• Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease? Kruidenier, L.; Verspaget, H. W. // Mediators of Inflammation;Jun98, Vol. 7 Issue 3, p157 

  OXIDATIVE damage is involved in the pathogenic process of idiopathic chronic inflammatory bowel disease. Although specific intervention in the oxidative cascade showed promising results in animal models and preliminary patient trials, the clinical efficacy of antioxidants still has to be...

• IMMUNOPATHOGENESIS OF IBD: INSUFFICIENT SUPPRESSOR FUNCTION IN THE GUT? Huibregtse, I. L.; Van Lent, A. U.; Van Deventer, S. J. H. // Gut;Apr2007, Vol. 56 Issue 4, p584 

  The article offers insights into evidence for abnormal regulation of T cell activation in Crohn's disease, as well as data concerning the existence and functional activity of regulatory T cells in the intestinal mucosa. Regulatory T cells have important functions in suppressing unwanted...

• Milk Fat Globule -- EGF Factor 8 Is a Critical Protein for Healing of Dextran Sodium Sulfate -- Induced Acute Colitis in Mice. Chogle, Ashish; Heng-Fu Bu; Xiao Wang; Brown, Jeffrey B.; Chou, Pauline M.; Xiao-Di Tan // Molecular Medicine;May/Jun2011, Vol. 17 Issue 5/6, p502 

  Milk fat globule-EGF factor 8 (MFG-E8) has been shown to play an important role in maintaining the integrity of the intestinal mucosa and to accelerate healing of the mucosa in septic mice. Herein, we (a) analyzed the expression of MFG-E8 in the gut of wild-type (WT) C57BL/6 (MFG-E8+/+) mice...

• The role of mucosal T lymphocytes in regulating intestinal inflammation. Uhlig, Holm; Powrie, Fiona // Springer Seminars in Immunopathology;Sep2005, Vol. 27 Issue 2, p167 

  Suppression of chronic intestinal inflammation by different subtypes of T cells has been described in recent years. In particular, naturally arising CD4+CD25+ regulatory T cells and IL-10-producing regulatory T cell type 1 CD4+ T lymphocytes have been implicated in the regulation of intestinal...

• Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. Naito, Yuji; Takagi, Tomohisa; Yoshikawa, Toshikazu // Journal of Gastroenterology;Oct2007, Vol. 42 Issue 10, p787 

  Neutrophil accumulation within epithelial crypts and in the intestinal mucosa directly correlates with clinical disease activity and epithelial injury in inflammatory bowel disease (IBD). Current advances have defined the mechanisms by which neutrophils are activated or migrate across...

Read the Article